Terumo Acquires 5% of Fuji Pharma To Grow Drug/Device Combo Product Business
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Japanese device maker Terumo Corp. reached an agreement to purchase 5 percent of Fuji Pharma common shares for jointly developing a drug and device combination product business in Japan - the first such convergence undertaking in a country where the government in the past administered the pharmaceutical and medical device markets almost separately